Aug 20, 2025 12:00
BBOT - BridgeBio Oncology Therapeutics, Inc. Common Stock
| Day | 1m | 10m | 60m | PreMarket | Market | AfterHours | Gap |
|---|---|---|---|---|---|---|---|
| 11.01 1.29 (11.72%) | --- | --- | 0.0 (0.0%) | --- | 0.94 (8.54%) | 0.25 (2.07%) | 0.25 (2.07%) |
BridgeBio Oncology Therapeutics Inc, formerly BridgeBio Oncology Therapeutics is a clinical-stage biotechnology company that aims to transform the lives of patients with cancers driven by RAS and PI3Ka, the two frequently mutated oncogenes.
Category:
PHARMACEUTICAL PREPARATIONS
Market Period:
Closed
Earnings & Ratios
- Basic EPS:
- Diluted EPS:
- Basic P/E:
- Diluted P/E:
- RSI(14) 1m:
- 100.0
- VWAP:
- 12.3
- RVol:
- 0.3975
Events
| Period | Kind | Movement | Occurred At |
|---|---|---|---|
| 1m | Price decrease 1m | 11.27 -0.12 (-1.01%) | Oct 15 10:15 |
| 1m | Price decrease 1m | 11.02 -0.19 (-1.65%) | Oct 15 10:05 |
| 1m | Price increase 1m | 11.19 +0.18 (+1.63%) | Oct 15 09:30 |